Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063899
Chunk: 418

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 418
---
 | For the Nine Months Ended 
 February 28,              
 2025                      | (493,710 
   15,102 
   24,312 
  150,526 
   31,406 
  (31,116 
   30,803 
   89,281 
  (34,293 
   49,980 
   24,774 
   12,890 
 (130,045 
        - 
        - 
  200,000 
  200,000 
   69,955 
   70,276 
  140,231 | ) 
 ) 
 ) 
 ) |     | February 29, 
 2024         | (455,673 
   15,039 
  159,405 
        - 
  (17,305 
   15,883 
   17,135 
  (75,760 
  (28,647 
  134,647 
   16,338 
   81,127 
 (137,811 
   (1,278 
   (1,278 
  100,000 
  100,000 
  (39,089 
  180,468 
  141,379 | ) 
 ) 
 ) 
 ) 
 ) 
 ) 
 ) 
 ) |
|:---------------------------------------------------------------------------------------|:----|:--------------------------|---------:|:--|:----|:-------------|---------:|:--|
| Discounts on note payable to founder                                                   |     | $                         |   24,970 |   |     | $            |   18,900 |   |
| Supplemental disclosure of cash flow information:                                      |     |                           |          |   |     |              |          |   |
| Cash paid for interest                                                                 |     | $                         |        - |   |     | $            |        - |   |
| Cash paid for taxes                                                                    |     | $                         |        - |   |     | $            |        - |   |

<div align='center'>See accompanying notes to condensed consolidated
financial statements

F-22

DIAMIR BIOSCIENCES CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div>

NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES

DiamiR Biosciences Corp. (“DiamiR” or the “Company”)
is a